These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2435558)

  • 21. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 22. Observations on isovolemic hemodilution in acute ischemic stroke.
    Comes L; Mureşan A; Costin Z
    Rom J Intern Med; 1996; 34(1-2):43-7. PubMed ID: 8908629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of effects of hydroxyethylstarch (HES 200/0.5) administered pre- and postoperatively in vascular surgery with dextran 40 (60) (author's transl)].
    Khosropour R; Lackner F; Steinbereithner K; Watzek C; Piza F; Wagner O; Amesberger C
    Anaesthesist; 1980 Nov; 29(11):616-22. PubMed ID: 6161557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Considerations in hemodilution therapy of stroke].
    Oder W; Kollegger H; Zeiler K; Deecke L
    Acta Med Austriaca; 1989; 16(5):109-14. PubMed ID: 2483488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global tissue oxygenation during normovolaemic haemodilution in young children.
    Aly Hassan A; Lochbuehler H; Frey L; Messmer K
    Paediatr Anaesth; 1997; 7(3):197-204. PubMed ID: 9189964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does colloid-induced plasma hyperviscosity in haemodilution jeopardize perfusion and oxygenation of vital organs?
    Krieter H; Brückner UB; Kefalianakis F; Messmer K
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):236-44. PubMed ID: 7540790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
    Kiesewetter H; Blume J; Jung F; Spitzer S; Wenzel E
    J Intern Med; 1990 Feb; 227(2):107-14. PubMed ID: 1688914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs.
    Thyes C; Madjdpour C; Frascarolo P; Buclin T; Bürki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
    Anesthesiology; 2006 Dec; 105(6):1228-37. PubMed ID: 17122586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiorespiratory function after replacement of blood loss with hydroxyethyl starch 120, dextran-70, and Ringer's acetate in pigs.
    Linko K; Mäkeläinen A
    Crit Care Med; 1989 Oct; 17(10):1031-5. PubMed ID: 2477191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheologic effects of plasma substitutes used for preoperative hemodilution.
    Audibert G; Donner M; Lefèvre JC; Stoltz JF; Laxenaire MC
    Anesth Analg; 1994 Apr; 78(4):740-5. PubMed ID: 7510937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative volume effect of HES 120/0.7 compared with dextran 70 and Ringer acetate.
    Hiippala S; Teppo AM
    Ann Chir Gynaecol; 1996; 85(4):333-9. PubMed ID: 9014063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Basic intensive care of ischemic cerebral stroke. Method of therapeutic hemodilution].
    Popov VV; Molchanov IV; Karpunichev OB; Poliakov AU; Kuznetsova IV; Gol'dina OA; Gorbachevskiĭ IuV
    Anesteziol Reanimatol; 2000; (4):44-9. PubMed ID: 11013997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly.
    Lehmann GB; Asskali F; Boll M; Burmeister MA; Marx G; Hilgers R; Förster H
    Br J Anaesth; 2007 May; 98(5):635-44. PubMed ID: 17456491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetic considerations in the use of plasma expanders.
    Klotz U; Kroemer H
    Clin Pharmacokinet; 1987 Feb; 12(2):123-35. PubMed ID: 2435442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II safety study.
    Rudolf J;
    Cerebrovasc Dis; 2002; 14(1):33-41. PubMed ID: 12097849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of dextran 60,000(D 60) and hydroxyethyl starch 450,000 (HES 450) on lymphocyte transformation].
    Khosropour R; Cerni C; Lackner F; Watzek C
    Anaesthesist; 1983 Jan; 32(1):25-7. PubMed ID: 6189413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypervolemic haemodilution and completed stroke: how important is the application time for its effect?
    Költringer P; Langsteger W; Reisecker F; Eber O
    Neurol Res; 1992; 14(2 Suppl):171-3. PubMed ID: 1355880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
    Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute normovolaemic haemodilution with a novel hydroxyethyl starch (130/0.4) reduces focal cerebral ischaemic injury in rats.
    Xiong L; Lei C; Wang Q; Li W
    Eur J Anaesthesiol; 2008 Jul; 25(7):581-8. PubMed ID: 18413007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.